CBL-B – An upcoming immune-oncology target

Riccardo Fusco, Zeinab Saedi, Imma Capriello, Andriy Lubskyy, Alexander Dömling

Open source

DOI: 10.1080/13543776.2024.2412567
Published: 2024-11-25
Container: Expert Opinion on Therapeutic Patents
Publisher: Informa UK Limited
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/13543776.2024.2412567,
  title = {CBL-B – An upcoming immune-oncology target},
  author = {Riccardo Fusco and Zeinab Saedi and Imma Capriello and Andriy Lubskyy and Alexander Dömling},
  year = {2024},
  journal = {Expert Opinion on Therapeutic Patents},
  doi = {10.1080/13543776.2024.2412567},
  url = {https://doi.org/10.1080/13543776.2024.2412567}
}

RIS

TY  - JOUR
TI  - CBL-B – An upcoming immune-oncology target
AU  - Riccardo Fusco
AU  - Zeinab Saedi
AU  - Imma Capriello
AU  - Andriy Lubskyy
AU  - Alexander Dömling
PY  - 2024
JO  - Expert Opinion on Therapeutic Patents
DO  - 10.1080/13543776.2024.2412567
UR  - https://doi.org/10.1080/13543776.2024.2412567
ER  -

APA

Fusco, R., Saedi, Z., Capriello, I., Lubskyy, A., & Dömling, A. (2024). CBL-B – An upcoming immune-oncology target. Expert Opinion on Therapeutic Patents. https://doi.org/10.1080/13543776.2024.2412567

Source records

crossref · retrieved 2026-09-25T17:24:04.796Z